Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TVAX-006 by Nanjing Yuandasai Weixin Biomedical for Herpes Zoster (Shingles): Likelihood of Approval
TVAX-006 is under clinical development by Nanjing Yuandasai Weixin Biomedical and currently in Phase I for Herpes Zoster (Shingles). According...